{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:13:52Z","timestamp":1761707632638},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.eururo.2003.11.008","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T12:09:41Z","timestamp":1070366981000},"page":"401-405","source":"Crossref","is-referenced-by-count":9,"title":["T1G3 Bladder Tumours: The Case for Conservative Treatment"],"prefix":"10.1016","volume":"45","author":[{"given":"William","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2003.11.008_BIB1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5347(17)51695-X","article-title":"Superficial bladder cancer: progression and recurrence","volume":"130","author":"Heney","year":"1983","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB3","unstructured":"Smith PH, Hall RR. Prognostic factors, treatment options and follow-up of Ta and T1 bladder tumours. In Hall RR, editor. The Clinical Management of Bladder Cancer. London: Arnold; 1997. p. 97\u2013118."},{"key":"10.1016\/j.eururo.2003.11.008_BIB4","unstructured":"Improving Outcomes in Urological Cancers. The Manual. Guidance on Cancer Services. London: National Institute for Clinical Excellence; 2002."},{"key":"10.1016\/j.eururo.2003.11.008_BIB5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005392-199907000-00018","article-title":"The value of a second transurethral resection in evaluating patients with bladder tumors","volume":"162","author":"Herr","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1464-410X.1991.tb15164.x","article-title":"Interpretation of biopsies of \u201cnormal\u201d urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group","volume":"67","author":"Richards","year":"1991","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-410X.1994.tb07487.x","article-title":"The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group","volume":"73","author":"Witjes","year":"1994","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-5347(17)52740-8","article-title":"Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference","volume":"128","author":"Skinner","year":"1982","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB9","first-page":"142","article-title":"High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor","volume":"15","author":"Herr","year":"1997","journal-title":"Semin. Urol. Oncol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB10","doi-asserted-by":"crossref","unstructured":"Oosterlinck W, Lobel B, Jakse G, Malmstr\u00f6m P-U, St\u00f6ckle M, Sternberg C. Guidelines on Bladder Cancer. Arnhem: European Association of Urology; 2003.","DOI":"10.1016\/S0302-2838(01)00026-4"},{"key":"10.1016\/j.eururo.2003.11.008_BIB11","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","article-title":"Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association","volume":"162","author":"Smith","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence","volume":"169","author":"Shahin","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(17)45923-4","article-title":"Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection","volume":"135","author":"Fitzpatrick","year":"1986","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/S0022-5347(05)64994-4","article-title":"Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance","volume":"167","author":"Griffiths","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(01)69072-4","article-title":"Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup","volume":"167","author":"Davis","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000049765","article-title":"Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861","volume":"40","author":"Jakse","year":"2001","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Martinez-Pineiro","year":"2002","journal-title":"BJU Int."},{"key":"10.1016\/j.eururo.2003.11.008_BIB19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0022-5347(05)65966-6","article-title":"Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial","volume":"166","author":"van der Meijden","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-4295(98)00212-X","article-title":"Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guerin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group","volume":"52","author":"Witjes","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.008_BIB21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/j.eururo.2003.11.008_BIB23","doi-asserted-by":"crossref","unstructured":"Shelley MD, Court JB, Kynaston H, Wilt TJ, Coles B, Mason M. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database Syst Rev 2003;CD003231.","DOI":"10.1002\/14651858.CD003231"},{"key":"10.1016\/j.eururo.2003.11.008_BIB24","doi-asserted-by":"crossref","unstructured":"Shelley MD, Court JB, Kynaston H, Wilt TJ, Fish RG, Mason M. Intravesical bacillus Calmette-Guerin in Ta and T1 bladder cancer. Cochrane Database Syst Rev 2000;CD001986.","DOI":"10.1002\/14651858.CD001986"},{"key":"10.1016\/j.eururo.2003.11.008_BIB25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity","volume":"169","author":"Bohle","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB26","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0022-5347(05)65074-4","article-title":"Analysis of early complications after radical cystectomy: results of a collaborative care pathway","volume":"167","author":"Chang","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB27","first-page":"723","article-title":"Radical cystectomy for invasive bladder cancer in the octogenarian","volume":"8","author":"Lance","year":"2001","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.eururo.2003.11.008_BIB28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0022-5347(05)65868-5","article-title":"Radical cystectomy is safe in elderly patients at high risk","volume":"166","author":"Chang","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0022-5347(01)68171-0","article-title":"Radical cystectomy in the octogenarian","volume":"158","author":"Stroumbakis","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB30","first-page":"336","article-title":"Relationship between postoperative in-hospital mortality and annual hospital volume of cystectomies: the effect of centers of experience","volume":"169","author":"Elting","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMsa012337","article-title":"Hospital volume and surgical mortality in the United States","volume":"346","author":"Birkmeyer","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eururo.2003.11.008_BIB32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0090-4295(97)00153-2","article-title":"Reconstruction of the urinary tract after radical cystectomy: the case for continent urinary diversion","volume":"49","author":"Turner","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.008_BIB33","unstructured":"Gospodarowicz MK, Warde P, Bristow RG. Radiotherapy for bladder cancer. In Hall RR, editor. The Clinical Management of Bladder Cancer. London: Arnold; 1997. p. 213\u201335."},{"key":"10.1016\/j.eururo.2003.11.008_BIB34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","article-title":"Contemporary management of stage T1 transitional cell carcinoma of the bladder","volume":"167","author":"Soloway","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","article-title":"Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience","volume":"59","author":"Pansadoro","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.008_BIB37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","article-title":"Intravesical bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours","volume":"41","author":"Patard","year":"2002","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eururo.2003.11.008_BIB39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-410X.1997.00431.x","article-title":"Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome","volume":"80","author":"Herr","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB40","unstructured":"van der Meijden APM. Bacillus Calmette-Gu\u00e9rin (BCG) for transitional cell carcinoma of the bladder. In Hall RR, editor. The Clinical Management of Bladder Cancer. London: Arnold; 1997. p. 125\u201343."},{"key":"10.1016\/j.eururo.2003.11.008_BIB41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0090-4295(01)00968-2","article-title":"P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy","volume":"57","author":"Slaton","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.11.008_BIB42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00005392-199909010-00020","article-title":"Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?","volume":"162","author":"Dalbagni","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB43","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2002.02.066","article-title":"Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin\u2014refractory transitional-cell carcinoma of the bladder","volume":"20","author":"Dalbagni","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eururo.2003.11.008_BIB44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1464-410X.1995.tb07307.x","article-title":"Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guerin for carcinoma in situ of the bladder","volume":"75","author":"Merz","year":"1995","journal-title":"Br. J. Urol."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T14:08:02Z","timestamp":1585318082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283803005785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0302283803005785"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2003.11.008","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}